Eikon Therapeutics, Inc.

EIKN · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
5
SEC Filings

Business Summary

Eikon Therapeutics, Inc. is a company operating under a 2026 Long-Term Incentive Plan, as described in this SEC filing. The filing excerpt pertains exclusively to the administration of the company's equity incentive plan, including award types such as Options, SARs, Restricted Stock, Restricted Stock Units, Unrestricted Stock, and Performance Awards. No specific products, services, or business operations are described in the provided text.

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionEIKNdiscussed_in_filing Blockchain & Crypto
topic_mentionEIKNdiscussed_in_filing Regulation
topic_mentionEIKNdiscussed_in_filing Healthcare & Bio
topic_mentionEIKNdiscussed_in_filing Sovereign & Government
topic_mentionEIKNdiscussed_in_filing Blockchain & Crypto
topic_mentionEIKNdiscussed_in_filing Regulation
topic_mentionEIKNdiscussed_in_filing Healthcare & Bio
topic_mentionEIKNdiscussed_in_filing Sovereign & Government
topic_mentionEIKNdiscussed_in_filing Blockchain & Crypto
topic_mentionEIKNdiscussed_in_filing Regulation
topic_mentionEIKNdiscussed_in_filing Healthcare & Bio
topic_mentionEIKNdiscussed_in_filing Sovereign & Government
topic_mentionEIKNdiscussed_in_filing Blockchain & Crypto
topic_mentionEIKNdiscussed_in_filing Regulation
topic_mentionEIKNdiscussed_in_filing Healthcare & Bio
topic_mentionEIKNdiscussed_in_filing Sovereign & Government

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001193125-26-130395EDGAR153K words

Quarterly Reports (10-Q)

No 10-Q filings indexed.

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-300001193125-26-130449EDGAR2K words
2026-02-060001193125-26-041201EDGAR—

5 total filings indexed. 2 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001861123
TickerEIKN
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 03741f2f21f4bf4c582c78a82b6d526d848b413e4843dc2ff5bf2a47b09c08f0
parent: 94fe1b82507d1a4b752c70ac4ed4c8804baa7a1634fd61e240f1f3ed98758445
content hash: efbc28badaeda7193a01d527782adab21ff7bb00ec081bbbac0b8564c53ba83b
signed: 2026-04-13T04:44:49.179Z
sources: 1 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf